InsiderTrades

Form 4 for HAYW Hayward Holdings, Inc.

Accepted 2026-07-01 17:24:35 ET · period of report 2026-06-30 · accession 0001851021-26-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-07-01 17:24 2026-06-30+ HAYW HOLLERAN KEVIN Pres, CEO, Dir M - OptEx $1.40 +170.0K 821.2K +26% +$238.0K
DMT 2026-07-01 17:24 2026-06-30+ HAYW HOLLERAN KEVIN Pres, CEO, Dir S - Sale+OE $17.22 -170.0K 701.2K -20% -$2.93M
DMT 2026-07-01 17:24 2026-06-30+ HAYW HOLLERAN KEVIN Pres, CEO, Dir M - OptEx $0.00 -170.0K 2.03M -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-30 M A 50,000 $1.40 751,234 D — — (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025.
2 Common Common Stock 2026-06-30 S D 50,000 $17.07 701,234 D — — (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 18, 2025. (F2) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.000 to $17.1450, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
3 Common Common Stock 2026-07-01 M A 120,000 $1.40 821,234 D — — (F3) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026
4 Common Common Stock 2026-07-01 S D 120,000 $17.28 701,234 D — — (F3) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2026 (F4) The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $17.0600 to $17.4050, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
5 Derivative Stock Options (Right to Buy) 2026-06-30 M D 50,000 $0.00 2,150,236 D $1.40 · 2021-08-12 to 2029-12-24 50,000 Common Stock
6 Derivative Stock Options (Right to Buy) 2026-07-01 M D 120,000 $0.00 2,030,236 D $1.40 · 2021-08-12 to 2029-12-24 120,000 Common Stock